Market Cap: $622.98M
SI
Solid Biosciences Inc.
SLDB
NASDAQ (NASDAQ Global Select)USD
Market Cap: $622.98M
Innovative Gene Therapy Takes Center Stage Amid DMD Patient Losses Recent fatalities involving two patients with Duchenne muscular dystrophy (DMD) have cast a spotlight on the urgent need for effectiv…
Gene Therapy Innovation in the Wake of Tragedy: Solid Biosciences' SGT-003 at the Forefront Recent fatalities involving two patients with Duchenne muscular dystrophy (DMD) underscore the urgent need f…
Solid Biosciences Advances Gene Therapy for Duchenne Muscular Dystrophy Solid Biosciences, a biotechnology firm focused on developing gene therapies for Duchenne muscular dystrophy (DMD), announces a…
Solid Biosciences Advances Gene Therapy Solutions for Duchenne Muscular Dystrophy Solid Biosciences, a biotechnology company focused on advancing innovative treatments for Duchenne Muscular Dystrophy…
Solid Biosciences Focuses on Advancing Gene Therapy Solutions Amid Market Volatility Solid Biosciences, a leader in gene therapy for Duchenne muscular dystrophy (DMD), continues to push forward with i…
Solid Biosciences Leverages Advancements in Gene Therapy for Duchenne Muscular Dystrophy Solid Biosciences, a biotechnology company focused on developing innovative gene therapies for Duchenne muscula…
Innovative Partnership Targets Age-Related Conditions through Klotho Protein Therapies Avant Technologies Inc. is making a strategic move into the burgeoning longevity biotechnology sector through a j…
Sarepta Therapeutics Enhances Elevidys Safety Measures for Duchenne Muscular Dystrophy Patients Sarepta Therapeutics, Inc. has recently issued a safety update regarding Elevidys (delandistrogene moxep…
Sarepta Therapeutics Enhances Safety Measures for DMD Gene Therapy Sarepta Therapeutics, Inc. takes significant steps to strengthen the safety profile of Elevidys (delandistrogene moxeparvovec-rokl),…
### Strategic Leadership Change at the FDA: Implications for Biologics Regulation The recent appointment of Vinay Prasad as the new director of the U.S. Food and Drug Administration’s Center of Biolog…